RESEARCH TRIANGLE PARK, N.C. – The Hamner Institutes for Health Sciences (www.thehamner.org), an independent, nonprofit organization that offers an open, collaborative and cross-disciplinary approach to translational biomedical research, says that recent studies at The Hamner have provided a new method to assess the health of the liver.
The blood tests physicians currently use to monitor liver health are not always accurate. Even when these tests are abnormal, they often do not indicate the cause of the liver problem.
Research reported in the May issue of Hepatology indicates that there may be a new way to analyze blood to view a window into the health of the liver. Small particles produced by the liver and circulating in the blood contain information that may used to better detect liver injury and could provide unique information to diagnose the cause of the injury.
The research was based on observations originally made by scientists at the drug company Pfizer, which has licensed patent rights for the technology to the Hamner Institutes for Health Sciences.
The study can be found at: http://www3.interscience.wiley.com/journal/123271400/abstract
Join hundreds of Marketing Professionals and Internet Execs at Atlanta’s premier Digital event – Digital Summit 2012
www.digitalsummit.com
Related Stories:
- Hamner Institutes, UNC establish Center for Drug Safety Sciences
- Hamner, Entelos team to create “virtual liver”
- Dow Chemical commits $5M to Hamner Institutes for chemical safety
- Hamner Institute research lands $25K grant
- NC’s Hamner Institutes researcher lands $2.1M NIH grant
© 2010, TechJournal. All rights reserved.
